Skip to content

Effectiveness of Osteopathic Manipulative Treatment (OMT) and Vestibular Rehabilitation Therapy (VRT) in Individuals With Vertigo

Effectiveness of Osteopathic Manipulative Treatment (OMT) and Vestibular Rehabilitation Therapy (VRT) Alone or in Combination on Balance and Visual Function in Individuals With Vertigo and Somatic Dysfunction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01529151
Enrollment
26
Registered
2012-02-08
Start date
2012-01-31
Completion date
2014-08-31
Last updated
2015-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vertigo, Dizziness, Benign Paroxysmal Positional Vertigo, Labyrinthitis

Keywords

Dizziness, Vertigo, Benign Paroxysmal Positional Vertigo, Labyrinthitis, Osteopathic Manipulative Treatment, Vestibular Rehabilitation Therapy

Brief summary

Western University of Health Sciences is seeking men and women to participate in a study on the effectiveness of Osteopathic Manipulative Treatment (OMT) and Vestibular Rehabilitation Therapy (VRT) in patients with vertigo. The purpose of this study is to examine the efficacy of OMT in the treatment of individuals with vertigo, alone and in combination with Vestibular Rehabilitation Therapy (VRT). Because of the health care costs associated with vertigo, the cost effectiveness of OMT and VRT will also be examined.

Interventions

OTHEROsteopathic Manipulative Treatment (OMT)

Direct action OMT procedures, including HVLA, involve the application of a force in the direction of restricted joint motion in order to resolve somatic dysfunction. Indirect techniques, including counterstrain, balanced ligamentous tension and myofascial release, entail applying a force away from the restrictive barrier of a joint or soft tissue structure.

Participants categorized as having a peripheral motion hypersensitivity will receive habituation exercises that reproduce the provocative motion, seated and standing balance exercises with gaze stabilization, kinesthetic and proprioceptive retraining. Participants will be given a monthly exercise log at onset and will be asked to report exercise levels at subsequent follow up periods.

Sponsors

Western University of Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 79 Years
Healthy volunteers
Yes

Inclusion criteria

* Symptoms of dizziness or a diagnosis of vertigo for longer than 3 months duration * Able to tolerate 30 minutes of sitting and standing * Able to transfer from sitting to standing and move independently * Able tolerate manual therapy and exercise

Exclusion criteria

* Severe traumatic injury * Bleeding disorders and anticoagulation (Coumadin) therapy * Currently receiving VRT, vision therapy, or manual medicine (OMT, Chiropractic, etc.) or received manual medicine within the past three months * Down syndrome * Ehlers-Danlos syndrome * Endolymphatic Hydrops * Legal blindness in one or both eyes * Menieres disease * Neurological conditions (including Peripheral Neuropathy, Stroke, traumatic brain injury, cerebral aneurysm, and Multiple Sclerosis) * Rheumatoid Arthritis * Spinal trauma or history of cervical spine surgery

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in Computerized Dynamic Posturography (CDP) at 12 weeksBaseline to 12 weeksComputerized dynamic posturography (CDP), also called test of balance (TOB), is a non-invasive specialized clinical assessment technique used to quantify the central nervous system adaptive mechanisms (sensory, motor and central) involved in the control of posture and balance, both in normal (such as in physical education and sports training) and abnormal conditions (particularly in the diagnosis of balance disorders and in physical therapy and postural re-education).
Change from Baseline in Dizziness Handicap Inventory (DHI) at 12 weeksBaseline to 12 weeksThe Dizziness Handicap Inventory (DHI) is a questionnaire that was developed to measure the self-perceived level of handicap associated with the symptom of dizziness.
Change from Baseline in Computerized Dynamic Posturography (CDP) at 1 weekBaseline to 1 weekComputerized dynamic posturography (CDP), also called test of balance (TOB), is a non-invasive specialized clinical assessment technique used to quantify the central nervous system adaptive mechanisms (sensory, motor and central) involved in the control of posture and balance, both in normal (such as in physical education and sports training) and abnormal conditions (particularly in the diagnosis of balance disorders and in physical therapy and postural re-education).
Change from Baseline in Computerized Dynamic Posturography (CDP) at 3 weeksBaseline to 3 weeksComputerized dynamic posturography (CDP), also called test of balance (TOB), is a non-invasive specialized clinical assessment technique used to quantify the central nervous system adaptive mechanisms (sensory, motor and central) involved in the control of posture and balance, both in normal (such as in physical education and sports training) and abnormal conditions (particularly in the diagnosis of balance disorders and in physical therapy and postural re-education).
Change from Baseline in Dizziness Handicap Inventory (DHI) at 1 weekBaseline to 1 weekThe Dizziness Handicap Inventory (DHI) is a questionnaire that was developed to measure the self-perceived level of handicap associated with the symptom of dizziness.
Change from Baseline in Dizziness Handicap Inventory (DHI) at 3 weeksBaseline to 3 weeksThe Dizziness Handicap Inventory (DHI) is a questionnaire that was developed to measure the self-perceived level of handicap associated with the symptom of dizziness.

Secondary

MeasureTime frameDescription
Change from Baseline in Neuro-Optometric Evaluation at 3 weeksBaseline to 3 weeksEvaluation of visual acuity and refractive status, oculomotor function and visual field status.
Change from Baseline in Neuro-Optometric Evaluation at 12 weeks.Baseline to 12 weeksEvaluation of visual acuity and refractive status, oculomotor function and visual field status.
Change from Baseline in Neuro-Optometric Evaluation at 1 weekBaseline to 1 weekEvaluation of visual acuity and refractive status, oculomotor function and visual field status.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026